Novel Immunotherapy Targets Cathepsin G in Solid Tumors
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Introduction:
• Cathepsin G (CG) is a serine
protease found in
Polymorphonuclear Neutrophils
(PMNs).
• Research suggests some leukemia
tumor cells can take up CG and
present its respective peptide
(CG1) on their surface.
• We hypothesize that CG can be
taken up by Non-Small Cell Lung
Cancer (NSCLC) cells and
Osteosarcoma (OS) cells and be
presented on their surface as novel
immunotherapy targets.

Methods:
• Standard cell culture procedure was
done for NSCLC, OS, U937
(histiocytic leukemia) and T2
(multiple myeloma) cell lines.
• Reverse transcriptase - polymerase
chain reaction (RT-PCR) was
performed to assess endogenous CG
mRNA.
• Cells were pulsed with a 10:1 ratio
of PMNs to malignant cell for 4
hours.
• Cells were stained with appropriate
antibodies, and we then performed
flow cytometry to determine CG
uptake.
• Cytotoxic Assay was performed to
assess percent killing when cells
were co-incubated with CG1
specific cytotoxic lymphocytes
(CTLs).

Results:
• RT-PCR showed no endogenous mRNA expression of CG in NSCLC/OS cells
lines (Figure 1).
• Flow cytometry analysis in H1650 (NSCLC) showed CG uptake with a 1.25fold increase in the CG-mean fluorescence intensity (CG-MFI) vs. nonpulsed cells (Figure 2).
• Flow cytometry analysis in Saos2 (OS) showed CG uptake with a two-fold
increase in the CG-MFI vs. non-pulsed cells (Figure 2).
• Cytotoxicity assay showed non-specific killing of both pulsed and control (T2)
control cells (Figure 3).
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Figure 1: RT-PCR show no endogenous
CG MRN in OS or NSCLC cell lines

Figure 2: A. CG uptake H1650 Non-Small Cell Lung Cancer cells (pulsed at a ratio of
10:1). B. CG uptake in SaOS2 Osteosarcoma cells (pulsed at a ratio of 7:1)

Figure 3: Cytotoxic Assay A.
T2 control B. H1650 NSCLC

Conclusions:
• Both OS and NSCLC show no endogenously express CG
• OS and NSCLC can take up CG when pulsed with irradiated PMNs
• The cytotoxicity assay was inconclusive, likely due to a high concentration of
CTLs.
• In the future, we will validate CG uptake in multiple OS and NSCLC cells lines
and hope to demonstrate dose-dependent cytotoxicity of target cells.

